WaferGen Bio-systems to Report First Quarter 2016 Financial Results on Tuesday, May 10
May 03, 2016 08:00 ET
|
WaferGen Bio-systems, Inc.
FREMONT, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (NASDAQ:WGBS), a life sciences tools company focused on developing and commercializing technology platforms for genomics...
XBiotech Appoints Amgen Veteran Scott Whitehurst as Chief Financial Officer
May 03, 2016 08:00 ET
|
XBiotech Inc.
AUSTIN, Texas, May 03, 2016 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT), developer of True Human™ therapeutic antibodies, announced the appointment of Scott Whitehurst as Chief Financial...
Zogenix to Release First Quarter 2016 Financial Results and Host Conference Call and Webcast on May 10
May 03, 2016 08:00 ET
|
Zogenix, Inc.
EMERYVILLE, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today...
REGENXBIO to Participate in May Investor Conferences
May 03, 2016 08:00 ET
|
REGENXBIO Inc.
ROCKVILLE, Md., May 03, 2016 (GLOBE NEWSWIRE) -- REGENXBIO Inc. (Nasdaq:RGNX), a leading biotechnology company focused on the development, commercialization and licensing of recombinant...
Cypress Reports Assay Results from Clayton Valley Lithium Project, Nevada
May 03, 2016 08:00 ET
|
Cypress Development Corp
VANCOUVER, British Columbia, May 03, 2016 (GLOBE NEWSWIRE) -- Cypress Development Corp. (TSX-V:CYP) (OTCBB:CYDVF) (Frankfurt:C1Z1) (“Cypress” or the “Company”) is pleased to announce, further to...
Immune Design to Report First Quarter 2016 Financial Results
May 03, 2016 08:00 ET
|
Immune Design Corp.
SEATTLE and SOUTH SAN FRANCISCO, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on cancer, today announced that it will...
Stemline Therapeutics Clears First Cohort of Patients in Ongoing SL-801 Phase 1 Trial
May 03, 2016 08:00 ET
|
Stemline Therapeutics, Inc.
NEW YORK, May 03, 2016 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that it has completed the initial dosing cohort in its SL-801 Phase 1 advanced solid tumor...
Momenta Pharmaceuticals Reports First Quarter 2016 Financial Results
May 03, 2016 08:00 ET
|
Momenta Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 03, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the first quarter ended March 31, 2016. For the first...
Pinnacle Entertainment Announces Conference Call for 2016 First Quarter Financial Results
May 03, 2016 08:00 ET
|
Pinnacle Entertainment, Inc.
LAS VEGAS, May 03, 2016 (GLOBE NEWSWIRE) -- Pinnacle Entertainment, Inc. (NASDAQ:PNK) announced today that it will release its 2016 first quarter results on Tuesday, May 10, 2016 prior to the...
A. M. Castle & Co. Announces Date for First Quarter 2016 Earnings Release – Tuesday, May 10, 2016
May 03, 2016 08:00 ET
|
A. M. Castle
OAK BROOK, Ill., May 03, 2016 (GLOBE NEWSWIRE) -- A. M. Castle & Co. (NYSE:CAS), a global distributor of specialty metal and supply chain services, announced today that it will release first...